In addition, NTN-1 promoter has been shown to be directly regulated by the NF-κB pathway in colorectal cancer, which allows us to suggest that a similar regulatory mechanism could occur in GBM (Figure 2) [75]. The gene discussed is NFKB1; the disease is glioblastoma.